X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs NOVARTIS - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA NOVARTIS FULFORD INDIA/
NOVARTIS
 
P/E (TTM) x 398.8 295.9 134.8% View Chart
P/BV x 6.2 25.2 24.7% View Chart
Dividend Yield % 0.1 1.4 5.9%  

Financials

 FULFORD INDIA   NOVARTIS
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
NOVARTIS
Mar-17
FULFORD INDIA/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs942855 110.2%   
Low Rs450666 67.6%   
Sales per share (Unadj.) Rs691.4219.0 315.7%  
Earnings per share (Unadj.) Rs11.519.1 60.0%  
Cash flow per share (Unadj.) Rs15.420.3 75.7%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.31.3 21.8%  
Book value per share (Unadj.) Rs380.0307.0 123.8%  
Shares outstanding (eoy) m3.9029.96 13.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.5 29.0%   
Avg P/E ratio x60.739.8 152.5%  
P/CF ratio (eoy) x45.337.5 121.0%  
Price / Book Value ratio x1.82.5 73.9%  
Dividend payout %17.452.4 33.3%   
Avg Mkt Cap Rs m2,71422,779 11.9%   
No. of employees `0000.40.7 65.9%   
Total wages/salary Rs m5051,393 36.3%   
Avg. sales/employee Rs Th6,073.09,736.2 62.4%   
Avg. wages/employee Rs Th1,137.42,066.8 55.0%   
Avg. net profit/employee Rs Th100.7849.0 11.9%   
INCOME DATA
Net Sales Rs m2,6966,562 41.1%  
Other income Rs m125702 17.9%   
Total revenues Rs m2,8227,264 38.8%   
Gross profit Rs m-46259 -17.9%  
Depreciation Rs m1536 42.3%   
Interest Rs m107 131.9%   
Profit before tax Rs m54917 5.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10345 2.8%   
Profit after tax Rs m45572 7.8%  
Gross profit margin %-1.73.9 -43.6%  
Effective tax rate %17.737.6 47.0%   
Net profit margin %1.78.7 19.0%  
BALANCE SHEET DATA
Current assets Rs m1,7389,731 17.9%   
Current liabilities Rs m5451,830 29.8%   
Net working cap to sales %44.3120.4 36.8%  
Current ratio x3.25.3 60.0%  
Inventory Days Days4849 99.5%  
Debtors Days Days425 17.1%  
Net fixed assets Rs m1257 20.8%   
Share capital Rs m39141 27.7%   
"Free" reserves Rs m1,4439,056 15.9%   
Net worth Rs m1,4829,196 16.1%   
Long term debt Rs m00-   
Total assets Rs m2,07711,499 18.1%  
Interest coverage x6.7128.4 5.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.6 227.5%   
Return on assets %2.65.0 51.8%  
Return on equity %3.06.2 48.5%  
Return on capital %4.310.1 42.8%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m17129 13.3%   
Fx outflow Rs m6731,734 38.8%   
Net fx Rs m-656-1,605 40.9%   
CASH FLOW
From Operations Rs m90-380 -23.7%  
From Investments Rs m1054,208 2.5%  
From Financial Activity Rs m-14-3,318 0.4%  
Net Cashflow Rs m181510 35.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 3.8 2.0 190.0%  
FIIs % 0.1 1.6 6.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 21.5 98.6%  
Shareholders   4,783 41,647 11.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   PANACEA BIOTECH  BIOCON LTD  J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - VENUS REMEDIES COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS